Connecting brain science & business

Science corner

Lancet Neurology

Title Filter

Display #

#	Article Title
1	[Articles] Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis
2	[Correspondence] Research into transmissibility of influenza A H5N1: a practical response to the controversy
3	[Articles] Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study
4	[Newsdesk] Global rabies elimination: are we stepping up to the challenge?
5	[Review] Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine
6	[Newsdesk] H5N1 research unleashed, almost
7	[Clinical Picture] Skin infection and progressive paraparesis
8	[Newsdesk] Highlights from the 22nd ECCMID
9	[Correspondence] Lyme disease antiscience – Authors' reply
10	[Media Watch] Eradication: ridding the world of diseases forever?
11	[Correspondence] Post-disaster assessment in Brazzaville, Congo
12	[Media Watch] Advances in virus research 79: research advances in rabies
13	[Correspondence] Lyme disease antiscience
14	[Review] Passive immunity in the prevention of rabies
15	[Editorial] Sinusitis and antibiotics
16	[Personal View] Is operational research delivering the goods? The journey to success in low-income countries
17	[Comment] The end of postoperative antimicrobial prophylaxis?
18	[Articles] Intraoperative versus extended antimicrobial prophylaxis after gastric cancer surgery: a phase 3, open-label, randomised controlled, non-inferiority trial
19	[Comment] Effects of malaria and its treatment in early pregnancy
20	[Comment] Rapid HIV tests: from meta-analysis to field application
21	[Media Watch] Germ theory
22	[Correspondence] Syphilis: still a major cause of infant mortality
23	[Media Watch] Treating drug-resistant tuberculosis
24	[Articles] A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial
25	[Correspondence] Syphilis: still a major cause of infant mortality – Authors' reply
26	[Articles] Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study
27	[Correspondence] Antibiotics by bolus or infusion for bacterial meningitis?
28	[Review] Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections
29	[Correspondence] Antibiotics by bolus or infusion for bacterial meningitis? – Authors' reply
30	[Clinical Picture] Chronic unilateral conjunctivitis
31	[Editorial] Testing for syphilis during pregnancy
32	[Correspondence] Diagnosis and treatment of pulmonary tuberculosis in patients with HIV
33	[Newsdesk] Russia's drug policy fuels infectious disease epidemics
34	[Correspondence] Diagnosis and treatment of pulmonary tuberculosis in patients with HIV – Author's reply
35	[Comment] Pre-ART HIV resistance testing in Africa: are we there yet?
36	[Newsdesk] Antibiotic use in livestock production in the USA
37	[Comment] Operational research and MDG tuberculosis control targets
38	[Profile] Jon Cohen: the rebirth of infectious diseases in the UK
39	[Comment] As India grows, tuberculosis control must not be left behind
40	[Articles] Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
41	[Comment] New EMA guideline for antimicrobial development
42	[Review] Optimisation of infection prevention and control in acute health care by use of behaviour change: a systematic review
43	[Comment] Progress with a difficult infection
44	[Media Watch] Infectious diseases–a geographic guide
45	[Comment] Cytomegalovirus vaccine: light on the horizon
46	[Comment] New studies of BCG: implications for tuberculosis vaccines
47	[Articles] Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial
48	[Review] Selection of chronic hepatitis B therapy with high barrier to resistance
49	[Clinical Picture] Disseminated cutaneous Mycobacterium chelonae
50	[Articles] Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study